Rchr
J-GLOBAL ID：201801011271575815   Update date: Nov. 17, 2024

Horibe Keizo

ホリベ ケイゾウ | Horibe Keizo
Affiliation and department：
NHO Nagoya Medical Cener Department of Pediatrics

About NHO Nagoya Medical Cener Department of Pediatrics


Job title： Part-time Doctor
Research field  (1)： Hematology and oncology
Research theme for competitive and other funds  (11)：
  • 2015 - 2019 An approach to establish pediatric hereditary cancer-related biomarkers applying DNA damage repair factors
  • 2012 - 2015 Basic Research to Establish the School Re-Entry Support Program for Children with Cancer
  • 2012 - 2015 Exploration for therapeutic target using a novel prognostic factor IKZF1 targeting cells in childhood acute lymphoblastic leukemia
  • 2010 - 2012 STUDY OF MINIMAL RESIDUAL DISEASE MEASUREMENTS AND CLINICAL APPLICATION IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
  • 2000 - 2002 Study on mechanism of ATRA-resistance and utility of MRD-monitoring in acute promyelocytic leukemia
Show all
Papers (299)：
  • Masahiro Yoshitomi, Shin-Ichi Tsujimoto, Junji Ikeda, Tomoko Kawai, Kentaro Ohki, Yusuke Hara, Genki Yamato, Reo Tanoshima, Daisuke Tomizawa, Akira Shimada, et al. High DOCK1 expression identifies a distinct prognostic subgroup of pediatric acute myeloid leukemia: Results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial. Pediatric blood & cancer. 2024. e31151
  • Shunsuke Kimura, Chun Shik Park, Lindsey E Montefiori, Ilaria Iacobucci, Petri Polonen, Qingsong Gao, Elizabeth D Arnold, Andishe Attarbaschi, Anthony Brown, Barbara Buldini, et al. Biologic and clinical analysis of childhood gamma delta T-ALL identifies LMO2/STAG2 rearrangements as extremely high-risk. Cancer discovery. 2024
  • Rintaro Ono, Kenichi Sakamoto, Ko Kudo, Aki Sato, Kazuko Kudo, Hisanori Fujino, Yuta Kawahara, Hiroya Hashimoto, Takehiko Doi, Ryu Yanagisawa, et al. Phase II study in children and adults under 40 years with newly diagnosed Langerhans cell histiocytosis: protocol for an LCH-19-MSMFB clinical trial in Japan. BMJ open. 2024. 14. 6. e084159
  • Mayumi Hangai, Takahisa Kawaguchi, Masatoshi Takagi, Keitaro Matsuo, Soyoung Jeon, Charleston W K Chiang, Andrew T Dewan, Adam J De Smith, Toshihiko Imamura, Yasuhiro Okamoto, et al. Genome-wide assessment of genetic risk loci for childhood acute lymphoblastic leukemia in Japanese patients. Haematologica. 2024. 109. 4. 1247-1252
  • Hideaki Ueki, Chitose Ogawa, Hiroaki Goto, Masanori Nishi, Junko Yamanaka, Shinji Mochizuki, Takuro Nishikawa, Tadashi Kumamoto, Ritsuo Nishiuchi, Atsushi Kikuta, et al. TBI, etoposide, and cyclophosphamide conditioning for intermediate-risk relapsed childhood acute lymphoblastic leukemia. International journal of hematology. 2024. 119. 4. 450-458
ｍore...
MISC (83)：
  • 大見 サキエ, 森口 清美, 畑中 めぐみ, 高木 歩実, 河合 洋子, 宮城島 恭子, 安田 和夫, 平賀 健太郎, 高橋 由美子, 堀部 敬三. がんの子どもを主人公とした絵本の道徳教育への活用可能性の検討. 椙山女学園大学看護学研究. 2022. 14. 15-26
  • 堀部 敬三. 小児がん医療・研究の課題と展望. 日本小児血液・がん学会雑誌. 2022. 58. 5. 331-339
  • 畑中 めぐみ, 清水 千佳子, 堀部 敬三. 地方自治体におけるAYA世代のがん患者への支援に関する実態調査. AYAがんの医療と支援. 2022. 2. 1. 1-7
  • 堀部 敬三. 【AYA世代のがん患者の包括的医療を目指して】AYA世代のがんの治療開発研究. 日本医師会雑誌. 2021. 150. 9. 1579-1582
  • 宮下 佳代子, 小林 京子, 山口 悦子[中上], 足立 壯一, 長谷川 大一郎, 岩本 彰太郎, 小林 良二, 照井 君典, 今村 俊彦, 嶋田 明, et al. 小児性骨髄性白血病(AML)経験者の就学・就労促進に関わる要因と支援. 日本小児血液・がん学会雑誌. 2021. 58. 1. 12-18
ｍore...
Education (2)：
  • 1980 - 1986 Nagoya University Graduate School of Medicine Pediatrics
  • 1972 - 1978 Nagoya University School of Medicine
Work history (11)：
  • 2019/04 - 現在 National Hospital Organization Nagoya Medical Center Department of Pediatrics Advisor
  • 2004/04 - 2019/03 National Hospital Organization Nagoya Medical Center Clinical Research Center Director of Clinical Research Center
  • 2004/01 - 2004/03 Nagoya National Hospital Clinical Research Center Director of Clinical Research Center
  • 2001/07 - 2004/03 Nagoya National Hospital Department of Pediatrics Manager
  • 1998/02 - 2001/06 Nagoya University Graduate School of Medicine Associate Professor
Show all
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM